Journal of the Academy of Nutrition and Dietetics
From the AcademyEvidence Analysis CenterDietary Macronutrient Distribution and Nutrition Outcomes in Persons with Cystic Fibrosis: An Evidence Analysis Center Systematic Review
Section snippets
Methods
This SR followed the methods of the Evidence Analysis Center at the Academy of Nutrition and Dietetics, which are described in detail elsewhere.16 This process aligns with the criteria delineated by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses.17 A brief description of methods including those specific to this SR are described below. This SR is part of a larger project addressing nutrition care in CF, which was registered prospectively at PROSPERO (CRD42018097373).18
Results
A Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart summarizing the results of the systematic search, including reasons for exclusion of full-text articles, is shown in Figure 2. The database searches identified 2,519 research articles with no additional records identified through other sources. After duplicates were removed, 2,409 titles/abstracts were screened and after the initial exclusion based on the titles and abstracts, 148 full-text articles were accessed
Discussion
Acceptable macronutrient distribution ranges for carbohydrate, fat, and protein for the general population are based on interventional trials and supportive epidemiological data to prevent or reduce risk of chronic diseases and to ensure sufficient dietary intakes of essential nutrients. Acceptable macronutrient distribution ranges for adults published in 2005 by the National Academy of Sciences are estimated to be 20% to 35% of total energy from fat and 45% to 65% from carbohydrates, with the
Conclusions
The current SR demonstrates wide ranges in the dietary macronutrient intakes of individuals with CF with little to no demonstrable effect of macronutrient distribution on nutrition-related outcomes. No evidence is presented to substantiate an outcomes-related benefit to a higher fat diet except in the context of achieving higher energy intakes in a lesser volume of food. The long-term consequences of a high-energy, high-fat, nutrient-poor diet for individuals with CF may be similar to the
Acknowledgements
The authors would like to acknowledge and thank the evidence analysts who extracted data for this systematic review. Primary institution where research was conducted: Academy of Nutrition and Dietetics.
Author Contributions
All authors were involved developing this systematic review from question formulation to evidence grading. C. M. McDonald, M. Rozga, E. K. Bowser, and K. Farnham wrote the first draft of this manuscript and all authors reviewed and commented on subsequent drafts of the manuscript.
C. M. McDonald is a clinical dietitian, Primary Children's Hospital, Salt Lake City, UT.
References (41)
- et al.
A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto
J Clin Epidemiol
(1988) - et al.
ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis
Clin Nutr
(2016) - et al.
Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: Results of a systematic review
J Am Diet Assoc
(2008) - et al.
The relative contribution of food groups to macronutrient intake in children with cystic fibrosis: A European multicenter assessment
J Acad Nutr Diet
(2019) - et al.
Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis
J Cyst Fibros
(2018) - et al.
Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: A population-based cohort study
Am J Clin Nutr
(2013) - et al.
Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis
J Cyst Fibros
(2020) - et al.
Academy of Nutrition and Dietetics methodology for conducting systematic reviews for the Evidence Analysis Library
J Acad Nutr Diet
(2016) - et al.
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
J Clin Epidemiol
(2009) - et al.
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
J Clin Epidemiol
(2011)
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
J Clin Epidemiol
GRADE guidelines: 3. Rating the quality of evidence
J Clin Epidemiol
Nutrient status of adults with cystic fibrosis
J Am Diet Assoc
Dietary intake and lipid profile in children and adolescents with cystic fibrosis
J Cyst Fibros
Glucose fluctuations are not modulated by the proportion of calories from macronutrients or spontaneous total energy expenditure in adults with cystic fibrosis
Can J Diabetes
Prevalence of dyslipidemia in adults with cystic fibrosis
J Cyst Fibros
Abnormal lipid concentrations in cystic fibrosis
Am J Clin Nutr
Cystic fibrosis dyslipidaemia: A cross-sectional study
J Cyst Fibros
Visceral adipose tissue is associated with poor diet quality and higher fasting glucose in adults with cystic fibrosis
J Cyst Fibros
Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications
J Gastroenterol Hepatol
Cited by (19)
Standards for the care of people with cystic fibrosis; establishing and maintaining health
2024, Journal of Cystic FibrosisNutritional considerations for a new era: A CF foundation position paper
2023, Journal of Cystic FibrosisStandards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis
2023, Journal of Cystic FibrosisCitation Excerpt :PwCF with one or two G551D variants in phase 3 trials of ivacaftor had sustained increases in weight and BMI [32]. PwCF with one or two F508del variants aged ≥12 years on elexacaftor-tezacaftor-ivacaftor had significant increases in weight and BMI [82]. Real-world studies of pwCF treated with ivacaftor also found consistent increases in weight and BMI [83].
Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era
2022, Clinics in Chest MedicineCitation Excerpt :More information is needed to determine how we can modify CF diets to reduce risk of cardiac disease in this population. The diet recommendations for PwCF have aimed for energy intake in 110% to 200% of non-CF individuals, with a high fat and high sodium intake to account for increased energy demands and sodium chloride losses in sweat41,42; this has become known as the legacy diet. There is a concern for age-related and metabolic conditions known to be associated with high fat, added sugar, high sodium diets, with low dietary quality.41,43
Improving nutrition in cystic fibrosis: A systematic literature review
2022, NutritionCitation Excerpt :Although the evidence identified in this review did not conclusively support a positive effect linked to using an app for CF nutritional management on anthropometric parameters, there was an improvement in QoL [25]. A recent systematic review was not able to identify and association between macronutrient distribution and BMI in adults [57] and a similar lack of association between anthropometric parameters and dietary contribution of protein, fat, and carbohydrates was observed in a pediatric study [41] identified in this review. However, evidence from a small RCT conducted by Gorji et al. suggests that deriving the carbohydrate contribution from low glycemic index sources enhances weight gain [22].
C. M. McDonald is a clinical dietitian, Primary Children's Hospital, Salt Lake City, UT.
E. K. Bowser is an associate in pediatrics and faculty nutritionist, Pediatric Pulmonary Division, University of Florida College of Medicine, Gainesville.
K. Farnham is a clinical pediatric dietitian, Nemours Children's Specialty Care, Jacksonville, FL.
J. A. Alvarez is an assistant professor of medicine, Emory University School of Medicine, Atlanta, GA.
L. Padula is an advanced practice dietitian, Children's Hospital of Philadelphia, Philadelphia, PA.
M. Rozga is a nutrition researcher, Academy of Nutrition and Dietetics, Evidence Analysis Center, Chicago, IL.
STATEMENT OF POTENTIAL CONFLICT OF INTEREST J. A. Alvarez receives funding from the National Institutes of Health (R03 DK117246, K01 DK102851), and the Cystic Fibrosis Foundation (ALVARE19A0). No other potential conflict of interest was reported by the authors.
FUNDING/SUPPORT This work was supported by the Academy of Nutrition and Dietetics and the Medical Nutrition Dietetic Practice Group of the Academy of Nutrition and Dietetics.